Images

Filter by

Design of the ISCHEMIA Trial
Design of the ISCHEMIA Trial
Trials Comparing Optimal Medical Therapy and Revascularisation in Chronic Coronary Disease
Trials Comparing Optimal Medical Therapy and Revascularisation in Chronic Coronary Disease
Events in Patients Receiving Dual Antiplatelet Therapy for ≤12 Months Versus &gt12 Months
Events in Patients Receiving Dual Antiplatelet Therapy for ≤12 Months Versus >12 Months
Anticoagulation and Antiplatelet Therapy in Chronic Total Occlusion Interventions
Anticoagulation and Antiplatelet Therapy in Chronic Total Occlusion Interventions
Comparison of Unfractionated Heparin Versus Bivalirudin Administration in Chronic Total Occlusion Interventions
Comparison of Unfractionated Heparin Versus Bivalirudin Administration in Chronic Total Occlusion Interventions
Comparison of Efficacy Outcomes Between Dual Antithrombotic Therapy with Dabigatran and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by the Presence of Clinical and/or Procedural Complexity Factors in the REDUAL PCI Trial Population
Comparison of Efficacy Outcomes Between Dual Antithrombotic Therapy with Dabigatran and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by the Presence of Clinical and/or Procedural Complexity Factors in the REDUAL PCI Trial Population
Comparison of Safety Outcomes Between Dual Antithrombotic Therapy with Dabigatran and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by the Presence of Clinical and/or Procedural Complexity Factors in the REDUAL PCI Trial Population
Comparison of Safety Outcomes Between Dual Antithrombotic Therapy with Dabigatran and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by the Presence of Clinical and/or Procedural Complexity Factors in the REDUAL PCI Trial Population
Comparison of Safety Outcomes Between Dual Antithrombotic Therapy with Rivaroxaban and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by Procedure and Lesion Characteristics in the PIONEER AF-PCI Trial Population
Comparison of Safety Outcomes Between Dual Antithrombotic Therapy with Rivaroxaban and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by Procedure and Lesion Characteristics in the PIONEER AF-PCI Trial Population
Comparison of Efficacy Outcomes Between Dual Antithrombotic Therapy with Rivaroxaban and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by Procedure and Lesion Characteristics in the PIONEER AF-PCI Trial Population
Comparison of Efficacy Outcomes Between Dual Antithrombotic Therapy with Rivaroxaban and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by Procedure and Lesion Characteristics in the PIONEER AF-PCI Trial Population
Major Randomized Controlled Trial Subgroup Analyses in Patients with AF Undergoing Complex Percutaneous Coronary Intervention
Major Randomized Controlled Trial Subgroup Analyses in Patients with AF Undergoing Complex Percutaneous Coronary Intervention
Criteria for Considering Patients for Minimally Invasive Coronary Artery Bypass Grafting Through Limited Thoracic Access
Criteria for Considering Patients for Minimally Invasive Coronary Artery Bypass Grafting Through Limited Thoracic Access
Summary of Transcatheter Mitral Valve Replacement Studies
Summary of Transcatheter Mitral Valve Replacement Studies